Paul H Huang

Cited by

	All	Since 2019
Citations	5627	3615
h-index	34	28
i10-index	76	71

920

460

230

690

20072008200920102011201220132014201520162017201820192020202120222023202419 62 97 142 151 169 173 224 229 212 251 251 329 442 662 854 916 381

Public access

View all

87 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Robin JonesROYAL MARSDEN AND INSTITUE OF CANCER RESEARCHVerified email at doctors.org.uk
Simon VyseInstitute of Cancer ResearchVerified email at icr.ac.uk
Lukas KrásnýPrincipal ScientistVerified email at hotmail.cz
Christopher P WildingInstitute of Cancer ResearchVerified email at nhs.net
Rachael NatrajanThe Institute of Cancer ResearchVerified email at icr.ac.uk
Frank FurnariUC San Diego, Dept of MedicineVerified email at ucsd.edu
Webster CaveneeLudwig Institute, University of California San DiegoVerified email at ucsd.edu
Seth M. PollackNorthwestern UniversityVerified email at northwestern.edu
Aik Choon TanHuntsman Cancer Institute, University of UtahVerified email at hci.utah.edu
Alex XuCedars-Sinai Medical CenterVerified email at cshs.org
Spyridon (Spyros) GennatasGuy's and St Thomas's NHS Foundation TrustVerified email at nhs.net
Amani ArthurDrVerified email at nhs.net
Rafael FridmanProfessor of Pathology & Oncology, Wayne State UniversityVerified email at med.wayne.edu
Birgit LeitingerImperial College LondonVerified email at imperial.ac.uk
Leo Kei IwaiResearch Scientist, Instituto ButantanVerified email at butantan.gov.br
Andrea NapolitanoRoyal Marsden Hospital, LondonVerified email at rmh.nhs.uk
Ryan A FlynnStem Cell Program, Boston Children's Hospital | Stem Cell and Regenerative Biology DepartmentVerified email at stanford.edu
Kiran V. Mahasenan, PhDKymera TherapeuticsVerified email at kymeratx.com
Shahriar MobasheryUniversity of Notre DameVerified email at nd.edu
Laura Paciniassegnista di ricerca, università di roma tor vergataVerified email at uniroma2.it

Paul H Huang

Team Leader, Molecular & Systems Oncology, Institute of Cancer Research, London, UK

Verified email at icr.ac.uk - Homepage

Sarcoma Lung Cancer Proteomics Receptor Tyrosine Kinases Signal Transduction


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma PH Huang, A Mukasa, R Bonavia, RA Flynn, ZE Brewer, WK Cavenee, ... Proceedings of the National Academy of Sciences 104 (31), 12867-12872, 2007	475	2007
Oncogenic EGFR signaling networks in glioma PH Huang, AM Xu, FM White Sci Signal 2 (87), re6, 2009	417	2009
Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer PT Harrison, S Vyse, PH Huang Seminars in Cancer Biology 61, 167-179, 2020	404	2020
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer S Vyse, PH Huang Signal Transduction and Targeted Therapy 4 (1), 5, 2019	322	2019
14-3-3σ controls mitotic translation to facilitate cytokinesis EW Wilker, MATM van Vugt, SC Artim, PH Huang, CP Petersen, ... Nature 446 (7133), 329-332, 2007	283	2007
Clinical and molecular spectrum of liposarcoma ATJ Lee, K Thway, PH Huang, RL Jones Journal of Clinical Oncology 36 (2), 151-159, 2017	243	2017
Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling HL Fu, RR Valiathan, R Arkwright, A Sohail, C Mihai, M Kumarasiri, ... Journal of Biological Chemistry 288 (11), 7430-7437, 2013	234	2013
Receptor tyrosine kinase coactivation networks in cancer AM Xu, PH Huang Cancer research 70 (10), 3857-3860, 2010	210	2010
Discoidin Domain Receptors Promote α1β1-and α2β1-Integrin Mediated Cell Adhesion to Collagen by Enhancing Integrin Activation H Xu, D Bihan, F Chang, PH Huang, RW Farndale, B Leitinger PLOS ONE 7 (12), e52209, 2012	159	2012
The Pathobiology of Collagens in Glioma LS Payne, PH Huang Molecular Cancer Research 11 (10), 1129-1140, 2013	154	2013
Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology L Krasny, PH Huang Molecular Omics 17 (1), 29-42, 2021	144	2021
Future Directions in the Treatment of Osteosarcoma A Smrke, PM Anderson, A Gulia, S Gennatas, PH Huang, RL Jones Cells 10 (1), 172, 2021	123	2021
Novel therapeutic approaches in chondrosarcoma G Polychronidou, V Karavasilis, SM Pollack, PH Huang, A Lee, RL Jones Future Oncology 13 (7), 637-648, 2017	119	2017
SWATH mass spectrometry as a tool for quantitative profiling of the matrisome L Krasny, P Bland, N Kogata, P Wai, BA Howard, RC Natrajan, PH Huang Journal of Proteomics, 2018	93	2018
Uncovering therapeutic targets for glioblastoma: a systems biology approach PH Huang, WK Cavenee, FB Furnari, FM White Cell Cycle 6 (22), 2750-2754, 2007	86	2007
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts S Stacchiotti, AB Miah, AM Frezza, C Messiou, C Morosi, A Caraceni, ... ESMO open 6 (3), 100170, 2021	84	2021
Primary cilia mediate diverse kinase inhibitor resistance mechanisms in cancer AD Jenks, S Vyse, JP Wong, E Kostaras, D Keller, T Burgoyne, ... Cell reports 23 (10), 3042-3055, 2018	84	2018
Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants LK Iwai, LS Payne, MT Luczynski, F Chang, H Xu, RW Clinton, A Paul, ... Biochemical Journal 454 (3), 501-513, 2013	84	2013
Direct Involvement of Retinoblastoma Family Proteins in DNA Repair by Non-homologous End-Joining R Cook, G Zoumpoulidou, MT Luczynski, S Rieger, J Moquet, ... Cell Reports 10 (12), 2006-2018, 2015	81	2015
EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism G Pines, PH Huang, Y Zwang, FM White, Y Yarden Oncogene 29 (43), 5850-5860, 2010	79	2010

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors